Inhibition of STAT-3 in tumor cells leads to down-regulation of its transcriptional targets belonging to the Bcl-2 family including the antiapoptotic Bcl-2, Bcl-XL and Mcl-1 [62]. The gene discussed is BCL2; the disease is neoplasm.